| 1,25(OH)2D3 | 1α,25-dihydroxyvitamin D3 |
| 25(OH)D3 | 25-hydroxyvitamin D3 |
| BCSCs | Breast cancer stem cells |
| BHT | Butylated hydroxytoluene |
| BuPB | Butylparaben |
| CAFs | Cancer-associated fibroblasts |
| CAT | Catalase |
| CIK | Cytokine-induced killer cell |
| CSCs | Cancer stem cells |
| DC | Dendritic cells |
| DHEA | Steroid dehydroepiandrosterone |
| DLT | Dose-limiting toxicity |
| EGCG | Epigallocatechin gallate |
| ER | Estrogen receptor |
| GSH | Glutathione |
| HER2 | Human epidermal growth factor receptor 2 |
| HPIMBD | 4-(E)-{(4-hydroxyphenylimino)-methylbenzene-1,2-diol} |
| HT | Hydroxytyrosol |
| ICD | Immunogenic cell death |
| ICT | Immune checkpoint therapies |
| IGF-1 | Insulin-like growth factor I |
| MDSCs | Myeloid-derived suppressor cells |
| NAC | N-acetylcysteine |
| NP | Not published |
| NPTs | Nanoparticles |
| PG | Propyl gallate |
| PIPN | Paclitaxel-induced peripheral neuropathy |
| PTX | Pentoxifylline |
| RA | Retinoic acid |
| RDS | Radiation dermatitis severity |
| ROCK-1 | Rho-associated kinase protein |
| SOD | Superoxide dismutase |
| STAT3 | Signal transducer and activator of transcription 3 |
| tBreg | Tumor-evoked regulatory b cells |
| TAM | Tumor-associated macrophages |
| TIMBD | 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol} () |
| TME | Tumor microenvironment |
| TNBC | Triple-negative breast cancer |
| TRF | Tocotrienol rich fraction |